Thanks to the likes (and behinds) of Kim Kardashian, Nicki Minaj, and JLo, buttock implants shot up 98% from 2013 to 2014, according to the latest report from the American Society of Plastic Surgeons.
Thinking of marketing breast augmentation with implants or breast lifts? Focus on January and February because this is when consumers make their decisions, RealSelf reports. During the past 4 years, these two months saw a 29% jump in breast augmentation and mastopexy lift questions versus the previous 10 months. This year, RealSelf saw a 32% jump in January and February versus the previous 10 months. Source: RealSelf
Silicone On Trial: Breast Implants and the Politics of Risk, by Jack C. Fisher, MD
In his new book, Fischer documents the rise, fall, and subsequent rise of silicone breast implants. It’s not a rant, but it does take the reader through silicone breast implants’ somewhat troubled history. In the end, the book emphasizes the safety of these devices and provides reassurance for patients concerned about the safety of silicone breast implants.
Pimecrolimus (Elidel) does not appear to increase the risk of cancer in kids, according to a Valeant-funded study by the journal JAMA Dermatology.
The researchers looked at nearly 7,500 children in the United States who were given an average of 793 grams of Pimecrolimus cream to treat eczema. The group was followed for 10 years. There were five cases of cancer diagnosed among the children: two leukemias, two lymphomas, and one bone cancer, as of May 2014. “It seems unlikely” that Pimecrolimus cream, as used in the study to treat eczema, is associated with an increased risk of cancer, the researchers conclude.